NEXIEN BIOPHARMA, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.5M

107 transactions

Summary

NEXIEN BIOPHARMA, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $1.4M8 insiders

Date	Insider	Type	Value
2024-05-23	Wasoff Evan L(Chief Financial Officer)	A	—
2024-05-23	Greenberg Richard S(Chief Executive Officer)	A	—
2023-10-31	Wasoff Evan L(Chief Financial Officer)	A	—
2023-10-31	Greenberg Richard S(Chief Executive Officer)	A	—
2023-07-25	Wasoff Evan L(Chief Financial Officer)	A	—
2023-07-25	Greenberg Richard S(Chief Executive Officer)	A	—
2023-07-25	Goldfarb Robert I(Chief Operating Officer)	A	—
2023-04-01	Greenberg Richard S(Chief Executive Officer)	A	—
2023-04-01	Wasoff Evan L(Chief Financial Officer)	A	—
2023-04-01	Goldfarb Robert I(Chief Operating Officer)	A	—
2023-01-17	Wasoff Evan L(Chief Financial Officer)	A	—
2023-01-17	Greenberg Richard S(Chief Executive Officer)	A	—
2023-01-17	Goldfarb Robert I(Chief Operating Officer)	A	—
2022-10-17	Wasoff Evan L(Chief Financial Officer)	A	—
2022-10-17	Greenberg Richard S(Chief Executive Officer)	A	—
2022-10-17	Goldfarb Robert I(Chief Operating Officer)	A	—
2022-07-27	Wasoff Evan L(Chief Financial Officer)	A	—
2022-07-27	Goldfarb Robert I(Chief Operating Officer)	A	—
2022-07-27	Greenberg Richard S(Chief Executive Officer)	A	—
2022-04-20	Wasoff Evan L(Chief Financial Officer)	A	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

NEXIEN BIOPHARMA, INC. — Contributions, Lobbying & Contracts | Poliscope